Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5

References

• Horr S, Nissen S. Managing hypertension in type 2 diabetes mellitus.Best. Pract Res Clin Endocrinol Metab. 2016;30(3):445–54.
   PubMed Web of Science ®Google Scholar
• Cryer MJ, Horani T, Dipette DJ. Diabetes and Hypertension: A Comparative Review of Current Guidelines. J Clin Hypertens (Greenwich). 2016;18(2):95–100.
   PubMed Web of Science ®Google Scholar
• Vong L, Ye C, Yang Z, Choi B, Chua S Jr, Lowell BB. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron. 2011;71(1):142–54.
   PubMed Web of Science ®Google Scholar
• López-Jaramillo P, Gómez-Arbeláez D, López-López J, Lopez-Lopez C, Martinez-Ortega J, Gomez-Rodriguez A, Triana-Cubillos S. The role of Leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig. 2014;18(1):37–45.
   PubMedGoogle Scholar
• Lee Y, Berglund ED, Wang MY, Fu X, Yu X, Charron MJ, Burgess SC, Unger RH. Metabolic manifestations of insulin deficiency do not occur without glucagon action. Proc Natl Acad Sci USA. 2012;109(37):14972–76.
   PubMed Web of Science ®Google Scholar
• Mele M, Iachetta G, Alò R,Avolio E, Fazzari G, Carelli A, Laforgia V, Canonaco M. Catestatin and GABA(A)R related feeding habits rely on dopamine, ghrelin plus Leptin neuroreceptor expression variations. Physiol Behav. 2016;157(1):225–30.
   Web of Science ®Google Scholar
• Uslu S, Kebapçi N, Kara M, Bal C. Relationship between adipoc ytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med. 2012;4(1):113–20.
   PubMed Web of Science ®Google Scholar
• Xin C, Liu J, Zhang J, Zhu D, Wang H, Xiong L, Lee Y, Ye J, Lian K, Xu C, et al. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int J Obes (Lond). 2016;40(3):443–51.
   PubMed Web of Science ®Google Scholar
• Palacios-González B, Vadillo-Ortega F, Polo-Oteyza E, Snchez T, Ancira-Moreno M, Romero-Hidalgo S, Merz N, Antuna-Puente B. Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with Leptin. Obesity (Silver Spring). 2015;23(4):729–32.
   PubMed Web of Science ®Google Scholar
• Quiñones M, Folgueira C, Sánchez-Rebordelo E, Al-Massadi O. Circulating irisin levels are not regulated by nutritional status, obesity, or Leptin levels in rodents. Mediators Inflamm. 2015;34(2):642–49.
   Google Scholar
• Zhu C, Zheng XF, Yang YH, Li B, Wang YR, Jiang SD, Jiang LS. LGR4 acts as a key receptor for R-spondin 2 to promote osteogenesis through Wnt signaling pathway. Cell Signal. 2016;28(8):989–1000.
   PubMed Web of Science ®Google Scholar
• Li JY, Chai BX, Zhang WZ, Fritze DM, Zhang C, Mulholland MW. LGR4 and its ligands, R-Spondin 1 and R-Spondin 3, regulate food intake in the hypothalamus of male rats. Endocrinology. 2014;155(2):429–40.
   PubMed Web of Science ®Google Scholar
• Deng D, Diao Z, Han X, Liu W. Secreted frizzled-related protein 5 attenuates high phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt/ß-catenin pathway. Calcif Tissue Int. 2016;99(1):66–75.
   PubMed Web of Science ®Google Scholar
• Carstensen-Kirberg M, Kannenberg JM, Huth C, Koenig W, Heier M, Peter A, Rathmann W, Roden M, Herder C, Thorand B. Inverse associations between serum levels of secreted frizzled-related protein-5 (Sfrp5) and multiple cardiometabolic risk factors: KORA F4 study. Cardiovasc Diabetol. 2017;16(1):1–10.
   PubMedGoogle Scholar
• Carstensen-Kirberg M, Hatziagelaki E, Tsiavou A, Chounta A, Nowotny P, Pacini G, Dimitriadis G, Roden M, Herder C. Sfrp5 associates with beta-cell function in humans. Eur J Clin Invest. 2016;46(6):535–43.
   PubMed Web of Science ®Google Scholar
• Shen T, Wang J, Yu Y, Yu J. Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: an electronic health recording system based study. Clin Exp Hypertens. 2018(2);1–11.
   PubMed Web of Science ®Google Scholar
• Nagalingam S, Uppuluri MV, Gunda P,Ravishanker U, Tirunilai P. Evaluation of Leptin and Leptin receptor gene 3ʹ UTR polymorphisms in essential hypertension. Clin Exp Hypertens. 2014;36(6):419–25.
   PubMed Web of Science ®Google Scholar
• Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA. 2010;107(40):17391–96.
   PubMed Web of Science ®Google Scholar
• Nishiguchi T, Yoshikawa Y, Yasui H. Anti-diabetic effect of organo-chalcogen (Sulfur and Selenium) zinc complexes with hydroxy-pyrone derivatives on Leptin-deficient type 2 diabetes model ob/ob mice. Int J Mol Sci. 2017;18(12):201–12.
   Web of Science ®Google Scholar
• Gu X, Chen Z, El Bayoumy I. Serum Leptin levels in obese women with and without type 2 diabetes mellitus. Minerva Endocrinol. 2014;39(3):223–29.
   PubMed Web of Science ®Google Scholar
• Kelly CB, Hookham MB, Yu JY, Lockhart SM, Du M, Jenkins AJ, Nankervis A, Hanssen KF, Henriksen T, Garg SK, et al. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes. Diabetologia. 2017;60(12):2514–24.
   PubMed Web of Science ®Google Scholar
• Xie C, Zhang Y, Tran TD, Wang H, Li S, George EV, Zhuang H, Zhang P, Kandel A, Lai Y, et al. Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One. 2015;10(8):e0136816.
   PubMed Web of Science ®Google Scholar
• Fu J, Han Y, Wang J, Liu Y, Zheng S, Zhou L, Joes PA, Zeng C. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat. J Am Heart Assoc. 2016;5(11):e003433.
   PubMed Web of Science ®Google Scholar
• Hu Z, Deng H, Qu H. Plasma Sfrp5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract. 2013;99(3):391–95.
   PubMed Web of Science ®Google Scholar
• Hu W, Li L, Yang M, Luo X, Ran W, Liu D, Xiong Z, Liu H, Yang G. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab. 2013;98(1):290–98.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu R, Wang F, Hong J, Li X, Chen M, Ke Y, Zhang X, Ma Q, Wang R, et al. Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch. Nat Cell Biol. 2013;15(12):1455–63.
   PubMed Web of Science ®Google Scholar
• Yi J, Xiong W, Gong X, Bellister S, Ellis LM, Liu Q. Analysis of LGR4 receptor distribution in human and mouse tissues. PLoS One. 2013;8(10):e78144.
   PubMed Web of Science ®Google Scholar